Switch theme
Sign up to access all valuation multiples
Heren Health Co Ltd is an overall solution service provider focusing on research and development, sales, implementation integration and service support of medical information systems and digital scenario application systems. Its products includes electronic medical records, medical information integration platform, clinical data centers, clinical pathway system, integrated health care workstations and operation control system of medical institutions.
2010
541
LTM Revenue n/a
LTM EBITDA n/a
$388M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Heren Health has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Heren Health achieved revenue of $60.5M and an EBITDA of $10.7M.
Heren Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Heren Health valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $60.5M | n/a | XXX | XXX | XXX |
| Gross Profit | $22.2M | $10.1M | XXX | XXX | XXX |
| Gross Margin | 37% | NaN% | XXX | XXX | XXX |
| EBITDA | $10.7M | n/a | XXX | XXX | XXX |
| EBITDA Margin | 18% | NaN% | XXX | XXX | XXX |
| Net Profit | $4.8M | -$11.5M | XXX | XXX | XXX |
| Net Margin | 8% | NaN% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Heren Health's stock price is CNY 12 (or $2).
Heren Health has current market cap of CNY 3.2B (or $437M), and EV of CNY 2.8B (or $388M).
See Heren Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $388M | $437M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Heren Health has market cap of $437M and EV of $388M.
Heren Health's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Heren Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Heren Health and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $388M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpHeren Health's NTM/LTM revenue growth is n/a
Heren Health's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $32K for the same period.
Over next 12 months, Heren Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Heren Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Heren Health and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $32K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 12% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 28% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Heren Health acquired XXX companies to date.
Last acquisition by Heren Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Heren Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Heren Health founded? | Heren Health was founded in 2010. |
| Where is Heren Health headquartered? | Heren Health is headquartered in China. |
| How many employees does Heren Health have? | As of today, Heren Health has 541 employees. |
| Is Heren Health publicy listed? | Yes, Heren Health is a public company listed on SHE. |
| What is the stock symbol of Heren Health? | Heren Health trades under 300550 ticker. |
| When did Heren Health go public? | Heren Health went public in 2016. |
| Who are competitors of Heren Health? | Similar companies to Heren Health include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of Heren Health? | Heren Health's current market cap is $437M |
| Is Heren Health profitable? | Yes, Heren Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
